HomeCompareWUXIF vs SBUX

WUXIF vs SBUX: Dividend Comparison 2026

WUXIF yields 0.94% · SBUX yields 2.75%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 WUXIF wins by $3.52M in total portfolio value· pulled ahead in Year 5
10 years
WUXIF
WUXIF
● Live price
0.94%
Share price
$13.88
Annual div
$0.13
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.68M
Annual income
$3,055,751.48
Full WUXIF calculator →
SBUX
SBUX
● Live price
2.75%
Share price
$89.59
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$157.5K
Annual income
$65,840.13
Full SBUX calculator →

Portfolio growth — WUXIF vs SBUX

📍 WUXIF pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodWUXIFSBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, WUXIF + SBUX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
WUXIF pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WUXIF
Annual income on $10K today (after 15% tax)
$79.61/yr
After 10yr DRIP, annual income (after tax)
$2,597,388.76/yr
SBUX
Annual income on $10K today (after 15% tax)
$233.40/yr
After 10yr DRIP, annual income (after tax)
$55,964.11/yr
At 15% tax rate, WUXIF beats the other by $2,541,424.65/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WUXIF + SBUX for your $10,000?

WUXIF: 50%SBUX: 50%
100% SBUX50/50100% WUXIF
Portfolio after 10yr
$1.92M
Annual income
$1,560,795.80/yr
Blended yield
81.29%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

WUXIF
No analyst data
Altman Z
9.8
Piotroski
7/9
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+16.1% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WUXIF buys
0
SBUX buys
0
No recent congressional trades found for WUXIF or SBUX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricWUXIFSBUX
Forward yield0.94%2.75%
Annual dividend / share$0.13$2.46
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%48.3%
Portfolio after 10y$3.68M$157.5K
Annual income after 10y$3,055,751.48$65,840.13
Total dividends collected$3.61M$127.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: WUXIF vs SBUX ($10,000, DRIP)

YearWUXIF PortfolioWUXIF Income/yrSBUX PortfolioSBUX Income/yrGap
1$10,887$187.32$11,107$407.21$220.00SBUX
2$12,031$381.20$12,512$626.87$481.00SBUX
3$13,660$787.34$14,366$978.69$706.00SBUX
4$16,287$1,671.00$16,929$1,557.50$642.00SBUX
5← crossover$21,152$3,724.08$20,658$2,543.80+$494.00WUXIF
6$31,672$9,039.75$26,406$4,302.22+$5.3KWUXIF
7$59,190$25,300.84$35,877$7,622.00+$23.3KWUXIF
8$151,713$88,379.99$52,741$14,352.64+$99.0KWUXIF
9$585,758$423,425.00$85,676$29,243.03+$500.1KWUXIF
10$3,682,512$3,055,751.48$157,513$65,840.13+$3.52MWUXIF

WUXIF vs SBUX: Complete Analysis 2026

WUXIFStock

WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, rest of Asia, the United States, Europe, and internationally. The company operates through six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; drug discovery services to pharmaceutical and biotech customers; and clinical research services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.

Full WUXIF Calculator →

SBUXConsumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this WUXIF vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WUXIF vs SCHDWUXIF vs JEPIWUXIF vs OWUXIF vs KOWUXIF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.